Brazilian Society of Bariatric and Metabolic Surgery - São Paulo (SP), Brazil.
Brazilian College of Digestive Surgery - São Paulo (SP), Brazil.
Arq Bras Cir Dig. 2023 Sep 15;36:e1759. doi: 10.1590/0102-672020230041e1759. eCollection 2023.
This Brazilian multi-society position statement on emerging bariatric and metabolic surgical procedures was issued by the Brazilian Society of Bariatric and Metabolic Surgery (SBCBM), the Brazilian College of Digestive Surgery (CBCD), and the Brazilian College of Surgeons (CBC). This document is the result of a Brazilian Emerging Surgeries Forum aimed at evaluating the results of surgeries that are not yet listed in the Federal Council of Medicine (CFM), the regulatory agency that oversees and regulates medical practice in Brazil. The Forum integrated more than 400 specialists and academics with extensive knowledge about bariatric and metabolic surgery, representing the three surgical societies: SBCBM, CBC, and CBCD. International speakers participated online and presented their experiences with the techniques under discussion, emphasizing the regulatory policies in their countries. The indications for surgery and the subsequent procedures were carefully reviewed, including one anastomosis gastric bypass (OAGB), single anastomosis duodeno-ileal with sleeve gastrectomy (SADI-S or OADS), sleeve gastrectomy with transit bipartition (SGTB), and sleeve gastrectomy with ileal interposition (SGII). The recommendations of this document are based on an extensive literature review and discussions among bariatric surgery specialists from the three surgical societies. We concluded that patients with a body mass index over 30 kg/m2 may be candidates for metabolic surgery in the presence of comorbidities (arterial hypertension and type 2 diabetes) with no response to clinical treatment of obesity or in the control of other associated diseases. Regarding the surgical procedures, we concluded that OAGB, OADS, and SGTB are associated with low morbidity rates, satisfactory weight loss, and resolution of obesity-related comorbidities such as diabetes and arterial hypertension. SGII was considered a good and viable promising surgical alternative technique. The recommendations of this statement aim to synchronize our societies with the sentiments and understandings of most of our members and also serve as a guide for future decisions regarding bariatric surgical procedures in our country and worldwide.
这份关于新兴减重与代谢外科手术的巴西多学会立场声明由巴西减重与代谢外科学会(SBCBM)、巴西消化外科学会(CBCD)和巴西外科学会(CBC)发布。这份文件是巴西新兴手术论坛的成果,旨在评估那些尚未列入巴西监管和规范医疗实践的机构——医学理事会(CFM)的手术的结果。该论坛整合了 400 多名专家和学者,他们在减重和代谢外科领域拥有丰富的知识,代表了三个外科学会:SBCBM、CBC 和 CBCD。国际演讲者在线参与并介绍了他们在讨论中的技术经验,强调了其所在国家的监管政策。手术的适应证和随后的手术程序都经过了仔细审查,包括单吻合口胃旁路术(OAGB)、单吻合口十二指肠空肠旁路袖状胃切除术(SADI-S 或 OADS)、袖状胃切除术与转流部分胃切除术(SGTB)和袖状胃切除术与回肠间置术(SGII)。本文件的建议基于对三个外科学会的减重外科专家进行的广泛文献回顾和讨论。我们得出结论,对于 BMI 超过 30kg/m2 的患者,如果存在肥胖相关并发症(高血压和 2 型糖尿病)且对肥胖的临床治疗无反应,或者在控制其他相关疾病方面存在问题,代谢手术可能是一种选择。对于手术程序,我们得出结论,OAGB、OADS 和 SGTB 与较低的发病率、令人满意的体重减轻以及肥胖相关并发症(如糖尿病和高血压)的解决相关。SGII 被认为是一种良好且可行的有前途的手术替代技术。本声明的建议旨在使我们的学会与大多数成员的意见和理解保持一致,并为我们国家和全球范围内未来的减重手术决策提供指导。